Literature DB >> 17240072

Predictors of mortality: a comparison between two burn wound treatment policies.

M Vehmeyer-Heeman1, C Van Holder, F Nieman, E Van den Kerckhove, W Boeckx.   

Abstract

Retrospective review of outcomes and experiences of a single burn centre between two time periods during which a new wound care technique was employed after the first period. The time period was divided into two: 1977-1984 and 1984-1990. Due to the use of cerium nitrate-silver sulphadiazine, the introduction of serial excision and grafting became possible in the second time period. Multivariate risk-analysis was done by logistic regression analysis. The mortality rate decreased from 13.7% (1997-1983) to 4.7% (1984-1990). Results of multiple logistic regression analysis indicate that the change in periods was advantageous for patients with >50% TBSA, within the age group, 0 to 30 years. Obviously, the care which a patient receives has improved significantly. Many developments occurred simultaneously and it appears impossible to conclude that only the use of cerium nitrate-silver sulphadiazine was the reason for improved survival. Nevertheless, the use of cerium nitrate-silver sulphadiazine enables sequential excision and grafting and in consequence allows for many of these developments to occur.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17240072     DOI: 10.1016/j.burns.2006.07.014

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  2 in total

1.  Economic burden of drug use in patients with acute burns: experience in a developing country.

Authors:  Kolawole Olubunmi Ogundipe; Ismaila Abiona Adigun; Babatunde Akeeb Solagberu
Journal:  J Trop Med       Date:  2009-08-31

2.  Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in burns care.

Authors:  Fabien Aujoulat; Françoise Lebreton; Sara Romano; Milena Delage; Hélène Marchandin; Monique Brabet; Françoise Bricard; Sylvain Godreuil; Sylvie Parer; Estelle Jumas-Bilak
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-06-24       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.